tradingkey.logo

Masimo Corp

MASI
查看详细走势图
139.150USD
+3.820+2.82%
收盘 02/06, 16:00美东报价延迟15分钟
7.39B总市值
亏损市盈率 TTM

Masimo Corp

139.150
+3.820+2.82%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+2.82%

5天

+1.33%

1月

+1.51%

6月

-3.97%

今年开始到现在

+6.99%

1年

-21.01%

查看详细走势图

TradingKey Masimo Corp股票评分

单位: USD 更新时间: 2026-02-06

操作建议

Masimo Corp当前公司基本面数据相对非常健康,最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理,在医疗设备与耗材行业排名35/205位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价183.53。中期看,股价处于平稳状态。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Masimo Corp评分

相关信息

行业排名
35 / 205
全市场排名
123 / 4521
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Masimo Corp亮点

亮点风险
Masimo Corporation is a global medical technology company that develops and produces a wide range of monitoring technologies, including measurements, sensors, patient monitors, automation and connectivity solutions. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. It primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
业绩转亏
公司业绩转亏,最新年度亏损美元
估值合理
公司最新PE估值-13.10,处于3年历史合理位
机构减仓
最新机构持股56.90M股,环比减少9.64%
CI 精选加拿大股票基金持仓
明星投资者CI 精选加拿大股票基金持仓,最新持仓市值408.00
活跃度增加
近期活跃度增加,过去20天平均换手率0.26

分析师目标

根据 10 位分析师
买入
评级
183.528
目标均价
+34.33%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Masimo Corp新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Masimo Corp简介

Masimo Corporation is a global medical technology company that develops and produces a wide range of monitoring technologies, including measurements, sensors, patient monitors, automation and connectivity solutions. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. It primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
公司代码MASI
公司Masimo Corp
CEOSzyman (Catherine M)
网址https://www.masimo.com/
KeyAI